InicioDEMG • LON
add
Deltex Medical Group plc
Cierre anterior
0,080 GBX
Intervalo anual
0,072 GBX - 0,20 GBX
Cap. bursátil
1,52 M GBP
Volumen medio
1,35 M
Relación precio-beneficio
-
Rentabilidad por dividendo
-
Bolsa de valores principal
LON
Noticias sobre los mercados
DOV
1,11 %
Datos financieros
Estado de resultados
Ingresos
Ingresos netos
(GBP) | jun 2024info | Cambio interanual |
---|---|---|
Ingresos | 532,00 mil | 0,47 % |
Gastos operativos | 576,50 mil | 0,70 % |
Ingresos netos | -273,00 mil | -1,68 % |
Margen de beneficio neto | -51,32 | -1,20 % |
Beneficios por acción | — | — |
EBITDA | -201,50 mil | -6,33 % |
Tipo impositivo efectivo | — | — |
Balance general
Activos totales
Responsabilidades totales
(GBP) | jun 2024info | Cambio interanual |
---|---|---|
Efectivo y a corto plazo | 326,00 mil | 204,67 % |
Activos totales | 5,50 M | -7,47 % |
Responsabilidades totales | 2,81 M | -31,48 % |
Patrimonio total | 2,69 M | — |
Acciones en circulación | 1891,93 M | — |
Precio-valor contable | ∞ | — |
Rentabilidad económica | -10,05 % | — |
Retorno sobre capital | -11,83 % | — |
Flujo de caja
Variación neta del flujo de caja
(GBP) | jun 2024info | Cambio interanual |
---|---|---|
Ingresos netos | -273,00 mil | -1,68 % |
Efectivo de operaciones | -217,50 mil | -42,62 % |
Efectivo de inversión | 1,00 mil | 100,83 % |
Efectivo de financiación | 21,50 mil | -77,37 % |
Variación neta del flujo de caja | -189,50 mil | -4,12 % |
Flujo de caja libre | -113,12 mil | 53,54 % |
Información sobre la empresa
Deltex Medical Group is a medical technology company based in Chichester that produces blood monitoring and fluid management equipment for use in surgical operations.
It has sold 3000 of its main product, the ultrasound probe CardioQ-ODM, which measures the rate of blood flow from the heart. The company claims that it has been shown to reduce postoperative complications and reduce length of hospital stay. According to the National Institute for Health and Care Excellence it could save £1000 per operation and could be used on more than 800,000 patients a year. As it is inserted into the gullet, it reduces the risk of infection that comes with monitoring using a tube inserted through a vein into the heart. Each probe costs about £100.
It secured approval from the NHS Supply Chain in 2012 after a tender process, to sell cardiac output monitoring equipment to the NHS in England, meaning that individual NHS trusts did not have to go through a tender process. In November 2016 an NHS hospital bought six, the largest order since 2014. The cash crisis affecting the NHS has meant that few machines have been bought. Wikipedia
Fundación
2000
Sitio web
Empleados
24